Graf Akcie IDRA (Idera Pharmaceuticals, Inc.). Diskuze k akciím IDRA. Aktuální informace IDRA.

Základní informace o společnosti Idera Pharmaceuticals, Inc. (Akcie IDRA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	53.29M
Hodnota podniku (EV)	24.84M
Tržby	0.00
EBITDA	-40.85
Zisk	4.79M
Růst v tržbách Q/Q	N/A %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	N/A
Forward P/E	-0.01
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	5.17
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	-0.58
Účetní hodnota na akcii	-1.59
Hotovost na akcii	0.66
FCF vůči ceně	-57.28 %
Počet zaměstnanců	32
Tržba na zaměstnance	0.00
Profit margin	17,623.43 %
Operating margin	N/A %
Gross margin	100.00 %
EBIT margin	N/A %
EBITDA margin	N/A %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-79.17 %
EPS - Očekávaný růst příští rok	-79.66 %
Return on assets	11.46 %
Return on equity	-43.97 %
ROIC	-250.67 %
ROCE	12.51 %
Dluhy/Equity	-1.47
Čistý dluh/EBITDA	3.63
Current ratio	7.21
Quick Ratio	7.21
Volatilita	4.57
Beta	0.86
RSI	31.87
Cílová cena analytiků	8
Známka akcie (dle analytiků)	N/A
Insider ownership	22.62 %
Institutional ownership	19.73 %
Počet akcií	52.762M
Procento shortovaných akcií	1.29 %
Short ratio	1.20 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2000
Země	United States

Finanční výsledky akcie IDRA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$1.448	$0.662	$0.902	$16.199	$0.249	$0.073
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	$1.448	$0.662	$0.902	$16.199	$0.249	$0.073
Research And Development Expenses	$34.853	$41.841	$50.653	$39.824	$33.699	$27.493
SG&A Expenses	$12.481	$15.42	$15.588	$15.132	$15.396	$11.332
Other Operating Income Or Expenses	-	-	-	-	-	-
Operating Expenses	$47.515	$61.618	$67.369	$54.956	$49.095	$38.825
Operating Income	$-46.067	$-60.956	$-66.467	$-38.757	$-48.846	$-38.752
Total Non-Operating Income/Expense	$-10.448	$1.075	$0.483	$0.368	$0.291	$0.11
Pre-Tax Income	$-56.515	$-59.881	$-65.984	$-38.389	$-48.555	$-38.642
Income Taxes	-	-	-	-	-	-
Income After Taxes	$-56.515	$-59.881	$-65.984	$-38.389	$-48.555	$-38.642
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-56.515	$-59.881	$-65.984	$-38.389	$-48.555	$-38.642
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-84.558	$-59.881	$-65.984	$-38.389	$-48.555	$-39.161
EBITDA	$-46.319	$-60.524	$-65.627	$-37.535	$-47.759	$-38.333
EBIT	$-46.067	$-60.956	$-66.467	$-38.757	$-48.846	$-38.752
Basic Shares Outstanding	29	27	20	16	14	10
Shares Outstanding	29	27	20	16	14	10
Basic EPS	$-2.96	$-2.25	$-3.35	$-2.41	$-3.36	$-3.76
EPS - Earnings Per Share	$-2.96	$-2.25	$-3.35	$-2.41	$-3.36	$-3.76

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$42.793	$71.431	$112.629	$109.014	$60.16	$41.227
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$3.475	$1.376	$3.992	$2.03	$3.082	$1.203
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$46.268	$72.807	$116.621	$111.044	$63.242	$42.43
Property, Plant, And Equipment	$0.097	$0.207	$1.472	$1.853	$1.692	$1.306
Long-Term Investments	-	-	-	-	$26.997	$7.344
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$0.07	$0.009	$0.324	$0.334	$0.345	$0.346
Total Long-Term Assets	$1.221	$0.216	$1.796	$2.187	$29.034	$8.996
Total Assets	$47.489	$73.023	$118.417	$113.231	$92.276	$51.426
Total Current Liabilities	$54.517	$9.018	$10.109	$9.353	$6.815	$7.046
Long Term Debt	-	-	-	$0.209	$0.501	$0.742
Other Non-Current Liabilities	$3.241	$0.011	$0.613	$0.168	$0.116	$0.236
Total Long Term Liabilities	$4.14	$0.011	$0.613	$0.529	$1.879	$0.978
Total Liabilities	$58.657	$9.029	$10.722	$9.882	$8.694	$8.024
Common Stock Net	$0.03	$0.027	$0.024	$0.149	$0.121	$0.095
Retained Earnings (Accumulated Deficit)	$-720.89	$-664.375	$-604.494	$-538.47	$-500.081	$-451.526
Comprehensive Income	-	-	-	$-0.017	$-0.134	$-0.017
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$-11.168	$63.994	$107.695	$103.349	$83.582	$43.402
Total Liabilities And Share Holders Equity	$47.489	$73.023	$118.417	$113.231	$92.276	$51.426

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-56.515	$-59.881	$-65.984	$-38.389	$-48.555	$-38.642
Total Depreciation And Amortization - Cash Flow	$-0.252	$0.432	$0.84	$1.222	$1.087	$0.419
Other Non-Cash Items	$15.526	$6.248	$10.87	$7.023	$5.707	$4.429
Total Non-Cash Items	$15.274	$6.68	$11.71	$8.245	$6.794	$4.848
Change In Accounts Receivable	-	-	-	-	-	-
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-	-
Change In Assets/Liabilities	$-2.16	$2.151	$-2.659	$-0.047	$0.484	$-0.329
Total Change In Assets/Liabilities	$-3.265	$1.285	$-0.985	$1.941	$-1.225	$2.473
Cash Flow From Operating Activities	$-44.498	$-51.916	$-55.259	$-28.203	$-42.986	$-31.321
Net Change In Property, Plant, And Equipment	-	$0.215	$-0.206	$-0.408	$-0.727	$-1.093
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	$-2.402	-	$28.27	$31.774	$-32.687	$-19.508
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	$-2.402	-	$28.27	$31.774	$-32.687	$-19.508
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$-2.402	$0.215	$28.064	$31.366	$-33.414	$-20.601
Net Long-Term Debt	$-0.006	$-0.217	$-0.303	$-0.268	$-0.13	$0.82
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	$-0.006	$-0.217	$-0.303	$-0.268	$-0.13	$0.82
Net Common Equity Issued/Repurchased	$0.124	$10.409	$5.697	$2.172	$2.546	$45.593
Net Total Equity Issued/Repurchased	$0.124	$10.409	$5.697	$2.172	$2.546	$45.593
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	$-0.798
Financial Activities - Other	$15.37	-	$53.763	$49.014	$80.599	-
Cash Flow From Financial Activities	$15.488	$10.192	$59.157	$50.918	$83.015	$45.615
Net Cash Flow	$-31.412	$-41.509	$31.962	$54.081	$6.615	$-6.307
Stock-Based Compensation	$3.845	$5.674	$10.72	$6.847	$5.442	$4.322
Common Stock Dividends Paid	-	-	-	-	-	$-0.798

#	2020	2019	2018	2017	2016	2015
Current Ratio	0.8487	8.0735	11.5364	11.8726	9.2798	6.0219
Long-term Debt / Capital	-	-	-	0.002	0.006	0.0168
Debt/Equity Ratio	-	-	0.0019	0.0048	0.0091	0.02
Gross Margin	100	100	100	100	100	100
Operating Margin	-3181.423	-9207.855	-7368.847	-239.2556	-19616.87	-53084.93
EBIT Margin	-3181.423	-9207.855	-7368.847	-239.2556	-19616.87	-53084.93
EBITDA Margin	-3198.826	-9142.599	-7275.721	-231.7119	-19180.32	-52510.96
Pre-Tax Profit Margin	-3902.97	-9045.468	-7315.299	-236.9838	-19500	-52934.25
Net Profit Margin	-5839.641	-9045.468	-7315.299	-236.9838	-19500	-53645.2
Asset Turnover	0.0305	0.0091	0.0076	0.1431	0.0027	0.0014
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	-	-	-	-
Days Sales In Receivables	-	-	-	-	-	-
ROE - Return On Equity	506.0455	-93.5729	-61.2694	-37.145	-58.0927	-89.0328
Return On Tangible Equity	506.0439	-93.5728	-61.2693	-37.145	-58.0927	-89.0328
ROA - Return On Assets	-119.0065	-82.0029	-55.7217	-33.9033	-52.6193	-75.141
ROI - Return On Investment	506.0441	-93.5728	-61.2693	-37.0701	-57.7465	-87.5362
Book Value Per Share	-0.3764	2.3538	4.4042	5.5465	5.514	3.6615
Operating Cash Flow Per Share	0.3928	0.8569	-1.0404	1.2197	0.0373	0.0973
Free Cash Flow Per Share	0.3847	0.8755	-1.0253	1.2447	0.0923	-0.0067

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/IDRA', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie IDRA (Idera Pharmaceuticals, Inc.). Diskuze k akciím IDRA. Aktuální informace IDRA.

Základní informace o společnosti Idera Pharmaceuticals, Inc. (Akcie IDRA)

Finanční výsledky akcie IDRA